Table 1 Limiting dilution assay for CD24, CD44, EpCAM and EpCAM/CD44 cells from xeno-B110 (first generation).

From: CD24, CD44 and EpCAM enrich for tumour-initiating cells in a newly established patient-derived xenograft of nasopharyngeal carcinoma

 

Cell inoculation number

Number of tumours/Number of inoculated mice

H2Kd neg

CD24 br

CD24 dim

CD44 br

CD44 dim

EpCAM br

EpCAM dim

EpCAM/CD44dbr

EpCAM/CD44ddim

xeno-B110

30,000

4/4

3/3

3/3

3/3

3/3

3/3

3/3

3/3

3/3

10,000

4/4

6/6

6/6

5/5

5/5

5/5

5/5

6/6

6/6

5,000

5/6

5/5

6/6

4/4

4/4

6/6

6/6

5/5

5/5

2,000

ND

5/5

4/4

5/5

3/5

5/5

4/5

5/5

5/5

500

3/3

3/3

3/3

3/3

3/3

3/3

2/3

3/3

2/3

100

2/6

2/6

1/6

5/6

1/6

3/6

2/6

5/6

1/6

10

0/6

1/6

0/6

2/6

2/6

0/6

0/6

1/6

0/6

Estimated TIC frequency (95% CI)

 

1 in 1177 (393–3526)

1 in 159 (63–404)

1 in 285 (108–754)

1 in 45 (18–110)

1 in 787 (333–1859)

1 in 147 (58–373)

1 in 730 (308–1728)

1 in 56 (23–135)

1 in 462 (181–1181)

p value

  

0.42

<0.001

0.01

<0.01

Enrichment factor (br/dim)

  

1.79

17.49

4.97

8.25

  1. ND, not determined.